Genetic Modification of Animals: Potential benefits and concerns

Genetic modification (GM), a process whereby gene and genotype frequencies are changed among individuals of each generation, is driven by  natural and artificial forces. Natural forces include mutation, fitness and migration/introgression, while artificial forces include selection,  crossbreeding and transgenesis/genetic engineering. Genetic modification, driven by natural forces, is essentially adaptive, while modification driven by artificial forces is controlled by human intervention aimed at meeting food, health and other needs. Conventional genetic modification, under sexual reproduction within species, produces both beneficial and negative effects. Modern genetic modification – interspecific exchange of genes using genetic engineering – has beneficial and negative effects as well, which are at varying degrees depending on the species involved. Control/management systems/mechanisms are developed and applied to enable societal benefits while minimizing/preventing negative effects of conventional and modern genetic modification. Targeted analysis of selected nutrients in animal products is made on a case-by-case basis to test substantial equivalence of any compositional changes resulting from genetic modification. Unique identifiers are established to track GM animals and their products in the food chain. Modification génétique, processus par lequel les fréquences des gènes et des génotypes sont changes parmi les individus de chaque génération, est entraînée par des forces naturelles et artificielles. Les forces naturelles incluent la mutation, compétence de mère/père pour se  reproduire/survivre et la migration / introgression. Les forces artificielles comprennent la sélection, le croisement et la transgénèse / génie génétique. La modification génétique entraînée par les forces naturelles est essentiellement adaptative, tandis que celle entraînée par les forces artificielles est contrôlée par une intervention humaine visant à répondre aux besoins alimentaires, sanitaires et autres. La modification génétique conventionnelle, lors de la reproduction sexuelle au sein des espèces, produit des effets à la fois bénéfiques et négatifs. Modification génétique moderne - échange interspécifique de gènes par génie génétique - a également des effets bénéfiques et négatifs mais à des degrés divers selon les espèces impliquées. Des systèmes / mécanismes de contrôle / gestion sont développés et appliqués pour permettre des avantages pour la société tout en minimisant / empêchant les effets négatifs des modifications génétiques conventionnelles et modernes. Une analyse ciblée de nutriments sélectionnés dans les produits d’origine animale est effectuée au cas par cas afin de tester l’équivalence substantielle de tout changement de composition résultant d’une modification génétique. Des identifiants uniques sont établis pour suivre les animaux GM et leurs produits dans la chaîne alimentaire

The Cameroon Academy of Sciences model of evidence-based science advice

The evidence-based science advice (ESA) effort of the Cameroon Academy of Sciences (CAS) since 23 years has been reviewed. The objective throughout has been to enable science influence policy/decision making at all levels – national, regional and global. The key partners of CAS included the United States National Academy of Sciences (USNAS), the German Academy of Sciences (Leopoldina), the Royal Society of United Kingdom, as well as the Network of African Science Academies (NASAC), the InterAcademy Partnership (Science, Health, Research), the Commonwealth Science Academies and the International Science Council. The mechanisms used included consensus studies, workshops, public lectures, participation in sectoral committees, summaries of key scientific publications and joint statements. Priorities handled through convening activities were triggered by policy/decision making sector requests or Academy foresights. The response/impact of the effort varied from media coverage through policy/programme change/orientation. The major challenges faced included insufficient financial/human resources, inadequate office space, and weak links with government. These challenges must be addressed to enable effective evidence-based science advice which is increasingly unavoidable for sustainable development.Keywords: Evidence-based science, advice, policy, decision-make

Seroprevalence of hepatitis C virus infection in patients with type 2 diabetes mellitus is associated with increased age in sub-Saharan Africa: Results from a cross-sectional comparative analysis

BackgroundSeveral epidemiological studies have established the association between hepatitis C virus (HCV) infection and type 2 diabetes mellitus (T2DM). However, the determinants and reasons for the high prevalence of HCV infection in people with T2DM are not well understood especially in sub-Saharan African populations. In this study, we aimed to assess determinants of the association between HCV infection and T2DM.MethodsWe performed a cross-sectional study amongst 442 T2DM patients recruited from an out-patient adult diabetes clinic in a tertiary hospital and 442 non-diabetic controls recruited from the general population. Serological testing for HCV antibody was performed using standard ELISA technique. Anti-HCV antibody prevalence was reported by age group in participants with diabetes and the non-diabetic controls. Logistic regression was used to examine for factors associated with the HCV infection in patients with diabetes.ResultsWe reported an overall HCV prevalence of 11.5% [95% CI: 9.4-13.6] irrespective of diabetes status in this study. The seroprevalence of HCV infection in diabetics patients was 17.6% [95% CI: 14.0-21.2] compared to 5.5% [95% CI: 3.4-7.6] in non-diabetics (p< 0.001). We did not find a significant HCV seropositivity difference in diabetic patients with common risk factors of HCV infection. When investigating the HCV seroprevalence by age group in diabetic and non-diabetic patients, no case of HCV infection was found in patients less than 30 years old while the highest HCV seropositivity was reported in patients older than 60 years (36.7% T2DM and 11.1% for non-diabetics) followed by the patients belonging to 50-59 years age group (16% in T2DM and 5.8% in non-diabetics) and those in 40-49 years age group (4.4% in diabetic, 0.8% in non-diabetic). To support this finding, in a multivariate logistic regression, only diabetic patients belonging to age group > 65 years had a significant risk (OR: 16.7 [95% CI: 1.7-160.0]) to acquire HCV infection.ConclusionThe seroprevalence of HCV infection is higher among T2DM adult patients than in non-diabetic patients, and is associated with increased age. This age-dependent association may suggest a generational exposure that may no longer exist overtime

CONFCAYS 2019 & Sub Regional Training Workshop on Science AdviceScience Advice in Africa: Opportunity or illusion: Young Scientists: Mainspring of innovation and development in Africa

International audienceThe Cameroon Academy of Young Scientists (CAYS) is a branch of the Cameroon Academy of Science (CAS) aimed at promoting research, paving the way for young scientists, encouraging the development of innovative approaches to national and international challenges. CAYS is a forum for building scientific capacities and the applicability of science to solve problems and provide decision makers and the public with advice based on the most up-to-date scientific knowledge. With support from MINRESI, MINTOUR, MINESUP, CAS, AUF and other partners, CAYS is organizing it first biennial international conference under the theme «Young Scientists: Mainspring of innovation and development in Africa » where scientists have opportunities to present their research results on diverse topics. More and more, scientific advice is spreading the world over to assist policy makers and politicians to make decisions that are informed by evidence-based data and scientific knowledge. It is an opportunity for dialogue that breaks or limits the gaps between researchers in different fields. In Africa and particularly in the Central African Sub-region, the progress of this concept is still lagging behind. Taking cognizance of this, CAYS offers an opportunity, during this conference, of a training workshop on the science advice in collaboration with The Quebec Research Funds (FRQ) and the International Network for Government Science Advice (INGSA). For the workshop, 65 participants were selected from government institutions and civil society organizations in the Central African Region. A total of 153 abstracts (55 oral and 98 poster presentations) were selected from national and international participants. The said abstracts will be presented in 4 sessions under 3 major themes including 1) Nutrition, Health and Environment; 2) Material Science, ITC and Renewable Energy; and 3) Digital Economy, Peace and Development. These abstracts have been compiled in this abstracts volume

Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon

BACKGROUND: Little is known on the magnitude and correlates of insulin resistance in HIV-infected people in Africa. We determined the prevalence of insulin resistance and investigated associated factors in HIV-infected adult Cameroonians. METHODS: We conducted a cross-sectional study at the Yaoundé Central Hospital, Cameroon; during which we enrolled HIV-infected people aged 30 to 74 years with no previous history of cardiovascular disease. An homeostatic model assessment of insulin resistance (HOMA-IR) like index served to assess insulin sensitivity with insulin resistance defined by values of 2.1 or higher. RESULTS: We included 452 patients (20% men). Their mean age was 44.4 ± 9.8 years and 88.5% of them were on antiretroviral therapy (93.3% on first line regimen including Zidovudine, lamivudine and Efavirenz/Nevirapine). Of all participants, 28.5% were overweight, 19.5% had obesity and 2.0% had diabetes. The prevalence of insulin resistance was 47.3% without any difference between patients on ART and those ART-naïve (48.5% vs. 38.5%; p = 0.480). Obesity was the only factor independently associated with insulin resistance (adjusted odds ratio: 2.28; 95% confidence interval: 1.10-4.72). CONCLUSION: Insulin resistance is present in nearly half of HIV-infected patients in Cameroon despite a low prevalence rate of diabetes, and is associated with obesity

Erratum to: Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study

Upon publication of the original article [1], it was noticed that the author\u2019s name \u201cJean Jacques Noubiap\u201d was incorrectly given as \u201cJean Jacques N. Noubiap\u201d. This has now been acknowledged and corrected in this erratum

Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study

Objective: This study aimed at investigating the association between the rs7903146 (C/T) polymorphism of the TCF7L2 gene with obesity in a Cameroonian population. Method: This was a case-control pilot study including 61 obese and 61 non-obese Cameroonian adults. Anthropometric indices of obesity, blood pressure, fasting blood glucose, and blood lipids were measured. The rs7903146 (C/T) polymorphism of the TCF7L2 gene was genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and genotypes were correlated with clinical and biological parameters. Results: The T allele was predominant in the study population with a frequency of 93%. No statistically significant difference was however observed between the genotypic (p = 0.50) and allelic frequencies (p = 0.58) of obese and non-obese subjects. Comparison of clinical and biochemical parameters of C allele carriers (CX = CC + CT) with those of TT genotype showed that there was no significant difference between the lipid profile of these two groups. Conclusion: The rs7903146 (C/T) polymorphism of the TCF7L2 gene might not be associated with obesity in the Cameroonian population

Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus : a systematic review protocol

CITATION: Mato, E. P. M. et al. 2018. Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus : a systematic review protocol. Systematic Reviews, 7:105, doi:10.1186/s13643-018-0773-y.The original publication is available at https://systematicreviewsjournal.biomedcentral.comBackground: Metformin is one of the most commonly used drugs for type 2 diabetes mellitus (T2DM). Despite its efficacy and safety, metformin is frequently associated with highly variable glycemic responses, which is hypothesized to be the result of genetic variations in its transport by organic cation transporters (OCTs). This systematic review aims to highlight and summarize the overall effects of OCT1 polymorphisms on therapeutic responses to metformin and to evaluate their potential role in terms of interethnic differences with metformin responses. Methods/design: We will systematically review observational studies reporting on the genetic association between OCT1 polymorphisms and metformin responses in T2DM patients. A comprehensive search strategy formulated with the help of a librarian will be used to search MEDLINE via PubMed, Embase, and CINAHL for relevant studies published between January 1990 and July 2017. Two review authors will independently screen titles and abstracts in duplicate, extract data, and assess the risk of bias with discrepancies resolved by discussion or arbitration of a third review author. Mined data will be grouped according to OCT1 polymorphisms, and their effects on therapeutic responses to metformin will be narratively synthesized. If sufficient numbers of homogeneous studies are scored, meta-analyses will be performed to obtain pooled effect estimates. Funnel plots analysis and Egger’s test will be used to assess publication bias. This study will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. Discussion: This review will summarize the genetic effects of OCT1 polymorphisms associated with variabilities in glycemic responses to metformin. The findings of this study could help to develop genetic tests that could predict a person’s response to metformin treatment and create personalized drugs with greater efficacy and safety. Systematic review registration: Registration number: PROSPERO, CRD42017079978https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0773-yPublisher's versio

Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol

Abstract Background Metformin is one of the most commonly used drugs for type 2 diabetes mellitus (T2DM). Despite its efficacy and safety, metformin is frequently associated with highly variable glycemic responses, which is hypothesized to be the result of genetic variations in its transport by organic cation transporters (OCTs). This systematic review aims to highlight and summarize the overall effects of OCT1 polymorphisms on therapeutic responses to metformin and to evaluate their potential role in terms of interethnic differences with metformin responses. Methods/design We will systematically review observational studies reporting on the genetic association between OCT1 polymorphisms and metformin responses in T2DM patients. A comprehensive search strategy formulated with the help of a librarian will be used to search MEDLINE via PubMed, Embase, and CINAHL for relevant studies published between January 1990 and July 2017. Two review authors will independently screen titles and abstracts in duplicate, extract data, and assess the risk of bias with discrepancies resolved by discussion or arbitration of a third review author. Mined data will be grouped according to OCT1 polymorphisms, and their effects on therapeutic responses to metformin will be narratively synthesized. If sufficient numbers of homogeneous studies are scored, meta-analyses will be performed to obtain pooled effect estimates. Funnel plots analysis and Egger’s test will be used to assess publication bias. This study will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. Discussion This review will summarize the genetic effects of OCT1 polymorphisms associated with variabilities in glycemic responses to metformin. The findings of this study could help to develop genetic tests that could predict a person’s response to metformin treatment and create personalized drugs with greater efficacy and safety. Systematic review registration Registration number: PROSPERO, CRD4201707997

Additional file 1: of Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol

PRISMA-P 2015 checklist. (DOC 82 kb